Herbal Medicine of the 21st Century: A Focus on the Chemistry, Pharmacokinetics and Toxicity of Five Widely Advocated Phytotherapies
Journal:
Current Topics in Medicinal Chemistry
Volume:
19
Page:
2718-2738
Author(s):
S. Suroowan and M.F. Mahomoodally*
Recent Patents on Radiotherapy Bed
Journal:
Recent Patents on Mechanical Engineering
Volume:
12
Page:
290-312
Author(s):
Yongde Zhang *, Xuesong Dai, Jingang Jiang, Zhikang Yang and Peiwang Qin
Acknowledgements to Reviewers
Journal:
Current Cancer Drug Targets
Volume:
19
Page:
930-930
Author(s):
Zoledronic Acid Inhibits the RhoA-mediated Amoeboid Motility of Prostate Cancer Cells
Journal:
Current Cancer Drug Targets
Volume:
19
Page:
807-816
Author(s):
Laura Pietrovito, Giuseppina Comito, Matteo Parri, Elisa Giannoni, Paola Chiarugi and Maria Letizia Taddei*
Hepatocyte Growth Factor and Macrophage-stimulating Protein “Hinge” Analogs to Treat Pancreatic Cancer
Journal:
Current Cancer Drug Targets
Volume:
19
Page:
782-795
Author(s):
John W. Wright*, Kevin J. Church and Joseph W. Harding
Polyisoprenylated Cysteinyl Amide Inhibitors Deplete K-Ras and Induce Caspase-dependent Apoptosis in Lung Cancer Cells
Journal:
Current Cancer Drug Targets
Volume:
19
Page:
838-851
Author(s):
Augustine T. Nkembo, Felix Amissah, Elizabeth Ntantie, Rosemary A. Poku, Olufisayo O. Salako, Offiong Francis Ikpatt and Nazarius S. Lamango*
Meet Our Section Editor
Journal:
Current Cancer Drug Targets
Volume:
19
Page:
853-853
Author(s):
S.K. Srivastava
Inhibition of PI3K/mTOR Pathways with GDC-0980 in Pediatric Leukemia: Impact on Abnormal FLT-3 Activity and Cooperation with Intracellular Signaling Targets
Journal:
Current Cancer Drug Targets
Volume:
19
Page:
828-837
Author(s):
Abdulhameed Al-Ghabkari*, Maneka A. Perinpanayagam and Aru Narendran
Mogroside V Inhibits Hyperglycemia-induced Lung Cancer Cells Metastasis through Reversing EMT and Damaging Cytoskeleton
Journal:
Current Cancer Drug Targets
Volume:
19
Page:
885-895
Author(s):
Jun Chen, Demin Jiao, Yu Li, Chunyan Jiang, Xiali Tang, Jia Song and Qingyong Chen*
Gefitinib Represses JAK-STAT Signaling Activated by CRTC1-MAML2 Fusion in Mucoepidermoid Carcinoma Cells
Journal:
Current Cancer Drug Targets
Volume:
19
Page:
796-806
Author(s):
Yufeng Wu, Zhen He, Shaomei Li, Hong Tang, Lili Wang, Sen Yang, Bing Dong, Jianjun Qin, Yue Sun, Han Yu, Yu Zhang, Yi Zhang, Yongjun Guo and Qiming Wang*